Day

januar 7, 2019
CAMBRIDGE, Mass., Jan. 07, 2019 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant (MDR) bacterial infections, and Everest Medicines announced today that they have entered into a collaboration to develop, manufacture and commercialize SPR206 in Greater China, South Korea and certain...

Nyheder

Din risikovillighed sidder i dine gener
15. januar 2019
Nyt ansøgningsprogram åbent for erfarne forskere
14. januar 2019
Gennemsigtige mus kortlægger hjernens vaskemaskine
4. januar 2019

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge